Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers

NCT05191862 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Randomization Error

Conditions

Intermittent Claudication

Interventions

DRUG: Cilostazol 100 mg
DRUG: PMR 135 mg

Sponsor

Genovate Biotechnology Co., Ltd.,